NCT07131605

Brief Summary

This research project aims to study how obesity affects the heart and metabolism, and how these effects change after significant weight loss following bariatric surgery. In particular, we want to look at how blood vessels and fat tissue function in people with obesity, to detect early signs of vascular problems and understand how fat tissue communicates with blood vessels. Our main idea is that obesity disrupts the normal function of blood vessels, partly due to substances released by fat tissue and changes in gut bacteria. We believe that 6 and 12 months after surgery - with proper weight loss - these problems will gradually improve. We expect to see better blood vessel function and lower levels of inflammation and fat-related substances in the blood, which could significantly reduce the overall risk of heart disease.

Trial Health

77
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
85

participants targeted

Target at P50-P75 for not_applicable

Timeline
6mo left

Started Nov 2024

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress74%
Nov 2024Nov 2026

Study Start

First participant enrolled

November 11, 2024

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

August 5, 2025

Completed
15 days until next milestone

First Posted

Study publicly available on registry

August 20, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 11, 2026

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 11, 2026

Last Updated

May 4, 2026

Status Verified

August 1, 2025

Enrollment Period

2 years

First QC Date

August 5, 2025

Last Update Submit

April 28, 2026

Conditions

Keywords

obesitycardiovascular risk

Outcome Measures

Primary Outcomes (2)

  • changes at the vascular tissue

    Measurement of circulating endothelial cells ( cells/µL)

    12 months

  • To analyze the changes adipose tissue

    Cardiac CT for assessment of epicardial adipose tissue. Volume quantification by tracing (cm³)

    from enrollment to the end of study at 12 month

Study Arms (1)

Patients who are hospitalized and undergoing either gastric bypass or sleeve gastrectomy surgery

OTHER
Other: Before bariatric surgery, both blood and biological samples (stool and urine) will be collected. Patients will also undergo a cardiology examination

Interventions

This study includes a comprehensive set of laboratory and clinical investigations to evaluate the cardiovascular and metabolic impact of obesity and its modulation after bariatric surgery. Multiple biological samples (blood, urine, stool, and omental adipose tissue) will be collected at baseline and during follow-up.

Patients who are hospitalized and undergoing either gastric bypass or sleeve gastrectomy surgery

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Adults (≥ 18 years old); Patients with obesity (Body Mass Index ≥ 30 kg/m²); Patients scheduled to undergo bariatric surgery via mini-gastric bypass or sleeve gastrectomy; Patients able to give their consent and to provide signed and dated informed consent for the processing of personal data; Willingness to attend follow-up visits and undergo all assessments required by the study protocol.

You may not qualify if:

  • Active systemic inflammatory diseases (e.g., chronic inflammatory bowel diseases, chronic rheumatologic diseases); Acute or chronic infections Severe anemia or coagulation disorders; Moderate to severe chronic kidney disease; Active malignancies.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Maria Cecilia Hospital

Cotignola, Ravenna, 48033, Italy

RECRUITING

MeSH Terms

Conditions

Obesity

Interventions

DefecationUrination

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Digestive System Physiological PhenomenaDigestive System and Oral Physiological PhenomenaUrinary Tract Physiological PhenomenaReproductive and Urinary Physiological Phenomena

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2025

First Posted

August 20, 2025

Study Start

November 11, 2024

Primary Completion (Estimated)

November 11, 2026

Study Completion (Estimated)

November 11, 2026

Last Updated

May 4, 2026

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

Individual participant data (IPD) will not be publicly shared. However, de-identified data may be made available to qualified researchers upon reasonable request to the study center and the Principal Investigator. All data will be processed in compliance with the General Data Protection Regulation (GDPR - EU Regulation 2016/679), ensuring the confidentiality, integrity, and protection of participants' personal information."

Locations